# US 2025/0082239 A1 · Systems and methods of managing substance use disorder of a person based on detected neurophysiological activity data

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082239 A1
- Document ID: US20250082239A1
- Status: Published application
- Kind: A1
- Application number: 18/748,153
- Filed: 2024-06-20
- Published: 2025-03-13
- Earliest claimed: 2023-06-26
- Assignees: University of Maryland, Baltimore County
- Applicants: University of Maryland, Baltimore County
- Inventors: Ramana Vinjamuri; Abhijit Dutt; Nilanjan Banerjee
- Web page: https://patentgrep.com/patent/US20250082239A1

## CPC

- A61B 5/16: Devices for psychotechnics (using teaching or educational appliances G09B1/00 - G09B7/00); Testing reaction times {; Devices for evaluating the psychological state}
- A61B 5/165: {Evaluating the state of mind, e.g. depression, anxiety}
- A61B 5/01: Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20)
- A61B 5/02405: {Determining heart rate variability}
- A61B 5/0245: by using sensing means generating electric signals, {i.e. ECG signals}
- A61B 5/0533: Measuring galvanic skin response
- A61B 5/0816: {Measuring devices for examining respiratory frequency (measuring frequency of electric signals G01R23/00)}
- A61B 5/374: Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
- A61B 5/384: Recording apparatus or displays specially adapted therefor
- A61B 5/486: {Biofeedback (using electroencephalography [EEG] A61B5/375)}
- A61B 5/7267: {involving training the classification device}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Systems and methods of managing substance use disorder of a person based on detected neurophysiological activity data are disclosed. According to an aspect, a system includes a biosensor configured to acquire neurophysiological activity data of a person. The system also includes a computing device comprising a substance use disorder manager configured to implement an application that interfaces with the person for managing the person's substance use disorder. The manager is also configured to receive the acquired neurophysiological activity data. Further, the manager is configured to determine that the person reached a substance abuse trigger point based on the acquired neurophysiological activity data. The manager is also configured to operate a user interface to present an interactive function of the application for distracting the person in response to determining that the person reached the subject abuse trigger point.

## Claims

### Claim 1

A system for managing substance use disorder of a person, the system comprising:
a biosensor configured to acquire neurophysiological activity data of a person;
a computing device comprising a substance use disorder manager configured to:
implement an application that interfaces with the person for managing the person's substance use disorder;
receive the acquired neurophysiological activity data;
determine that the person reached a substance abuse trigger point based on the acquired neurophysiological activity data; and
operate a user interface to present an interactive function of the application for distracting the person in response to determining that the person reached the subject abuse trigger point.

### Claim 2 (depends on 1)

The system of claim 1, wherein the biosensor comprises one of an electroencephalography (EEG) or an electrodermal activity (EDA).

### Claim 3 (depends on 1)

The system of claim 1, wherein the biosensor is configured to output an electrical signal indicative of the neurophysiological activity data and to communicate the electrical signal to the computing device.

### Claim 4 (depends on 1)

The system of claim 1, wherein the computing device comprises a smartphone.

### Claim 5 (depends on 1)

The system of claim 1, wherein the biosensor is configured to be worn by the person.

### Claim 6 (depends on 1)

The system of claim 1, further comprising one or more other biosensors configured to acquire other neurophysiological activity data of the person, and
wherein the substance use disorder manager is configured to determine that the person reached a substance abuse trigger point based on the other acquired neurophysiological activity data.

### Claim 7 (depends on 1)

The system of claim 1, wherein the user interface comprises one of a display or a speaker.

### Claim 8 (depends on 1)

The system of claim 1, wherein the substance use disorder manager is configured to implement an algorithm for determining the substance abuse trigger point based on the acquired neurophysiological activity data.

### Claim 9 (depends on 1)

The system of claim 1, wherein the substance use disorder manager is configured to implement an artificial intelligence or machine learning algorithm for determining the substance abuse trigger point based on the acquired neurophysiological activity data.

### Claim 10 (depends on 1)

The system of claim 1, wherein the substance use disorder manager is configured to:
idle the interactive function of the application;
enable the interactive function of the application; and
manage whether the interactive function of the application is idled or enabled based on the neurophysiological activity data received from the biosensor.

### Claim 11 (depends on 1)

The system of claim 1, wherein the interactive function of the application comprises a stimulus for distracting from substance abuse.

### Claim 12 (depends on 1)

The system of claim 1, wherein the interactive function of the application comprises a function that presents a cognitive-behavioral therapy (CBT) interface, a neuro feedback interface, a game, or a neuro stimulation activity to the user.

### Claim 13

A method for managing substance use disorder of a person, the method comprising:
providing a biosensor configured to acquire neurophysiological activity data of a person;
implementing an application that interfaces with the person for managing the person's substance use disorder;
receiving the acquired neurophysiological activity data;
determining that the person reached a substance abuse trigger point based on the acquired neurophysiological activity data; and
operating a user interface to present an interactive function of the application for distracting the person in response to determining that the person reached the subject abuse trigger point.

### Claim 14 (depends on 13)

The method of claim 13, wherein the biosensor comprises one of an electroencephalography (EEG) or an electrodermal activity (EDA).

### Claim 15 (depends on 13)

The method of claim 13, wherein the biosensor is configured to output an electrical signal indicative of the neurophysiological activity data and to communicate the electrical signal to the computing device.

### Claim 16 (depends on 13)

The method of claim 13, wherein the biosensor is configured to be worn by the person.

### Claim 17 (depends on 13)

The method of claim 13, further comprising:
providing one or more other biosensors configured to acquire other neurophysiological activity data of the person; and
determining that the person reached a substance abuse trigger point based on the other acquired neurophysiological activity data.

### Claim 18 (depends on 13)

The method of claim 13, wherein the user interface comprises one of a display or a speaker.

### Claim 19 (depends on 13)

The method of claim 13, further comprising implementing an algorithm for determining the substance abuse trigger point based on the acquired neurophysiological activity data.

### Claim 20 (depends on 13)

The method of claim 13, further comprising implementing an artificial intelligence or machine learning algorithm for determining the substance abuse trigger point based on the acquired neurophysiological activity data.

### Claim 21 (depends on 13)

The method of claim 13, further comprising:
idling the interactive function of the application;
enabling the interactive function of the application; and
managing whether the interactive function of the application is idled or enabled based on the neurophysiological activity data received from the biosensor.

### Claim 22 (depends on 13)

The method of claim 13, wherein the interactive function of the application comprises a stimulus for distracting from substance abuse.

### Claim 23 (depends on 13)

The method of claim 13, wherein the interactive function of the application comprises a function that presents a cognitive-behavioral therapy (CBT) interface, a neuro feedback interface, a game, or a neuro stimulation activity to the user.
